Nexacare Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 17-11-2024
- Paid Up Capital ₹ 0.10 M
as on 17-11-2024
- Company Age 8 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 26.10%
(FY 2023)
- Profit -27.25%
(FY 2023)
- Ebitda -20.61%
(FY 2023)
- Net Worth -937.63%
(FY 2023)
- Total Assets -8.61%
(FY 2023)
About Nexacare Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rajesh Rijhwani, Yash Rijhwani, and Nimish Rijhwani serve as directors at the Company.
- CIN/LLPIN
U36109DL2016PTC299848
- Company No.
299848
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 May 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Nexacare Lifesciences Private Limited offer?
Nexacare Lifesciences Private Limited offers a wide range of products and services, including Protein Supplements, Amino Acids.
Who are the key members and board of directors at Nexacare Lifesciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yash Rijhwani  | Director | 17-May-2016 | Current |
| Rajesh Rijhwani | Director | 17-May-2016 | Current |
| Nimish Rijhwani | Director | 17-May-2016 | Current |
Financial Performance of Nexacare Lifesciences.
Nexacare Lifesciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 26.1% increase. The company also saw a substantial fall in profitability, with a 27.25% decrease in profit. The company's net worth observed a substantial decline by a decrease of 937.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nexacare Lifesciences?
In 2023, Nexacare Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nexacare Lifesciences?
Unlock and access historical data on people associated with Nexacare Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nexacare Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nexacare Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
